Issue 28 of Multiple Myeloma Research Review.
Highlights include:
- Elotuzumab monotherapy for smouldering MM
- Thereapetuc vulnerability of MM to Pri-17-92 inhibition
- Identification of novel mutational drivers reveals oncogene dependencies in MM
- Patient reported health-related Q0L from TOURMALINE-MM1